Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Gastroenterology. 2023 Jul 25;165(4):963–975.e5. doi: 10.1053/j.gastro.2023.06.036

Figure 4.

Figure 4.

Significant differences in serum interleukin 6 (A), TNFα (B), and IL-13 (C) were seen when stratifying patients by high or low visceral adipose tissue (IA-VAT) burden. 1SFDR is defined as a Harvey Bradshaw Index <5 or partial Mayo score <2 and normal C-reactive protein/fecal calprotectin while off steroids. 2IA-VAT, intra-abdominal visceral adipose tissue. 3High IA-VAT burden was defined as equal or higher to median IA-VAT of the population (≥1% of the total body mass). 4High IA-VAT burden was defined as less than the median IA-VAT of the population (<1% of the total body mass). *P value for differences among groups (Kruskal–Wallis Test).